The Molecular Biology of Ependymomas

Ronald L Hamilton; Ian F Pollack

doi:10.1111/j.1750-3639.1997.tb01066.x

. 2008 Jan 28;7(2):807–822. doi: 10.1111/j.1750-3639.1997.tb01066.x

The Molecular Biology of Ependymomas

Ronald L Hamilton ^1,^✉, Ian F Pollack ²

PMCID: PMC8098521 PMID: 9161731

Abstract

Intracranial ependymomas are the third most common primary brain tumor in the pediatric population. Although an anaplastic variant is recognized, numerous studies examining the prognostic implications of histological features, such as necrosis, endothelial proliferation and mitoses, have yielded contradictory results. In order to improve outcome prediction in affected patients and to refine therapeutic decision‐making, there is a strong need for identifying relevant biological correlates of tumor behavior. The molecular biology of tumors is a rapidly expanding field and includes investigations into cytogenetics, oncogenes, growth factors, growth factor receptors, hormonal receptors, proliferation markers, apoptosis, cell cycle genes and cell adhesion molecules, as well as factors potentially related to therapeutic resistance, such as the multidrug resistance gene. The molecular biology of astrocytic tumors in adults has been the subject of many studies; however, relatively few studies have been focused on ependymomas. Herein we review potential oncological markers in ependymomas that have been identified to date and highlight the limitations of our current knowledge as a basis for defining areas for future investigation.

Full Text

The Full Text of this article is available as a PDF (2.2 MB).

References

1. Afra D., Muller W., Slowik F., Wilcke O., Budka H., Turoczy L. (1983) Supratentoriai lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir 69: 243–251. [DOI] [PubMed] [Google Scholar]
2. Antonlades HN, Galanopolos T., Noville‐Golden J., Maxwell M. (1992) Expression of insulinlike growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50: 215–222. [DOI] [PubMed] [Google Scholar]
3. Arnoldus EP, Wolters LB, Voormolen JH, van Duinen SG, Raap AK, van der Ploeg M., Peters AC (1992) Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. J Neurosurg 76: 997–1003. [DOI] [PubMed] [Google Scholar]
4. Asai A., Hoshino T., Edwards MS, Davis RL (1992) Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv Syst 8: 273–278. [DOI] [PubMed] [Google Scholar]
5. Awaad YM, Allen JC, Miller DC, Schneider SJ, Wisoff J. Epstein FJ (1996) Deferring adjuvant therapy for totally resected intracranial ependymoma. Ped Neurol 14: 216–219. [DOI] [PubMed] [Google Scholar]
6. Barone BM, Elvidge AR (1970) Ependymomas. A clinical survey. J Neurosurg 33: 428–438. [DOI] [PubMed] [Google Scholar]
7. Becker I., Becker KF, Meyermann R., Hollt V. (1991) The multidrug‐resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82: 516–519. [DOI] [PubMed] [Google Scholar]
8. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Eng J Med 326: 988–993. [DOI] [PubMed] [Google Scholar]
9. Bigner SH, Wong AJ, Mark J., Muhlbaier LH, Kinzler KW, Vogelstein B., Bigner DD (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29: 165–170. [DOI] [PubMed] [Google Scholar]
10. Bijlsma EK, Voesten AM, Bijleveld EH, Troost D., Westerveld A., Merel P., Thomas G., Hulsebos TJ (1995) Molecular analysis of genetic changes in ependymomas. Genes Chromosom Cancer 13: 272–277. [DOI] [PubMed] [Google Scholar]
11. Bloom HJ, Glees J., Bell J., Ashley SE, Gorman C. (1990) The treatment and long‐term prognosis of children with intracranial tumors: a study of 610 cases, 1950–1981. Int J Radiat Oncol Biol Phys 18: 723–745. [DOI] [PubMed] [Google Scholar]
12. Brodeur GM, Seeger RC, Schwab M., Varmus HE, Bishop JM (1984) Amplification of N‐myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124. [DOI] [PubMed] [Google Scholar]
13. Burger P., Scheithauer B. (1994) Tumors of the central nervous system. Atlas of tumor pathology 3rd series, Fascicle 10, Armed Forces Institute of Pathology: Washington DC . [Google Scholar]
14. Chiu JK, Woo SY, Ater J., Connelly J., Bruner JM, Maor MH, van Eys J., Oswald MJ, Shallenberger R. (1992) Intracranial ependymoma in children: analysis of prognostic factors. J Neuro-onc 13: 283–290. [DOI] [PubMed] [Google Scholar]
15. Chou PM, Barquin N., Gonzalezcrussi F., Sanz CR, Tomita T., Reyesmugica M. (1996) Ependymomas in children express the multidrug resistance gene immunohistochemical and molecular biologic study. Ped Pathol Lab Med 16: 551–561. [PubMed] [Google Scholar]
16. Cogen PH (1991) Prognostic significance of molecular genetic markers in childhood brain tumors. Ped Neurosurg 17: 245–250. [DOI] [PubMed] [Google Scholar]
17. Cogen PH, Daneshvar L., Metzger AK, Duyk G., Edwards MS, Sheffield VC (1992) Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Med Genet 50: 584–589. [PMC free article] [PubMed] [Google Scholar]
18. Collins VP, James CD (1993) Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7: 926–930. [DOI] [PubMed] [Google Scholar]
19. Corallini A., Pagnani M., Viadana P., Silini E., Mottes M., Milanesi G., Gerna G., Vettor R., Trapella G., Silvani V., et al. (1987) Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer 39: 60–67. [DOI] [PubMed] [Google Scholar]
20. Coulon RA, Till K. (1977) Intracranial ependymomas in children: a review of 43 cases. Childs Brain 3: 154–168. [PubMed] [Google Scholar]
21. Dal Cin P., Sandberg AA (1988) Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 30: 289–293. [DOI] [PubMed] [Google Scholar]
22. Debiec‐Rychter M., Lasota J., Alwasiak J., Liberski PP (1995) Recurrent anaplastic ependymoma with an abnormal karyotype and c‐myc proto‐oncogene overexpression. Acta Neuropathol 89: 270–274. [DOI] [PubMed] [Google Scholar]
23. DeMonte F., Al‐Mefty O. (1995) Meningiomas. In: Brain Tumors, Kaye A., Laws E. Jr. (eds.), pp. 675–704, Churchill Livingstone: New York , NY . [Google Scholar]
24. Diedrich U., Eckermann O., Schmidtke J. (1988) Rare Haras and c‐mos alleles in patients with intracranial tumors. Neurology 38: 587–589. [DOI] [PubMed] [Google Scholar]
25. Diedrich U., Soja S., Behnke J., Zoll B. (1991) Amplification of the c‐erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue. J Neurol 238: 221–224. [DOI] [PubMed] [Google Scholar]
26. Dohrmann GJ, Farwell JR, Flannery JT (1976) Ependymomas and ependymoblastomas in children. J Neurosurg 45: 273–283. [DOI] [PubMed] [Google Scholar]
27. Duffner P., Cohen M., Voorhess M., MacGillivray M., Brecher M., Panahon A., Gilani B. (1985) Long‐term effects of cranial irradiation on endocrine function in children with brain tumors: a prospective study. Cancer 56: 2189–2193. [DOI] [PubMed] [Google Scholar]
28. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, et al. (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Eng J Med 328: 1725–1731. [DOI] [PubMed] [Google Scholar]
29. Dumanski JP, Rouleau GA, Nordenskjold M., Collins VP (1990) Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863–5867. [PubMed] [Google Scholar]
30. Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH (1992) Spinal MR findings in neurofibromatosis types 1 and 2 . Am J Neuradiol 13: 1071–1077. [PMC free article] [PubMed] [Google Scholar]
31. Ekstrand AJ, James CD, Cavenee WK, Seliger B., Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo . Cancer Res 51: 2164–2172. [PubMed] [Google Scholar]
32. Ellenberg L. McComb J., Siegel S., Stowe S. (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurg 21: 638–644. [DOI] [PubMed] [Google Scholar]
33. Ernestus RI, Schroder R., Stutzer H., Klug N. (1996) Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 12:522–526. [DOI] [PubMed] [Google Scholar]
34. Ernestus RI. Wilcke O., Schroder R. (1989) Intracranial ependymomas: prognostic aspects. Neurosurg Rev 12: 157–163. [DOI] [PubMed] [Google Scholar]
35. Ernestus RI, Wilcke O., Schroder R. (1991) Supratentorial ependymomas in childhood: clinicopathological findings and prognos s. Acta Neurochir 111: 96–102. [DOI] [PubMed] [Google Scholar]
36. Evans AE, Anderson JR, Lefkowitz‐Boudreaux IB, Finlay JL (1996) Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio‐spinal irradiation with or without adjuvart CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediarr Oncol 27: 8–14. [DOI] [PubMed] [Google Scholar]
37. Ferrante L., Mastronardi L., Schettini G., Lunardi P., Fortuna A. (1994) Fourth ventricle ependymomas. A study of 20 cases with survival analysis. Acta Neurochir 131: 67–74. [DOI] [PubMed] [Google Scholar]
38. Figarella‐Branger D., Gambarelli D., Dollo C., Devictor B., Perez‐Castillo AM, Genitori L., Lena G., Choux M., Peilissier JF (1991) Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post‐operative survival in 16 cases. Acta Neuropathol 82: 208–216. [DOI] [PubMed] [Google Scholar]
39. Figarella‐Branger D., Lepidi H., Poncet C., Gambarelli D., Bianco N., Rougon G., Pellissier JF (1995) Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors. Acta Neuropathol 89: 248–257. [DOI] [PubMed] [Google Scholar]
40. Fink KL, Rushing EJ, Schold SC, Jr. , Nisen PD (1996) Infrequency of p53 gene mutations in ependymomas. J Neuro-Oncol 27: 111–115. [DOI] [PubMed] [Google Scholar]
41. Friedman HS, Krischer JP, Burger P., Oakes WJ, Hockenberger B., Weiner MD, Falletta JM, Norris D., Ragab AH, Mahoney DH, Jr. , et al. (1992) Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10: 249–256. [DOI] [PubMed] [Google Scholar]
42. Fujimoto M., Sheridan PJ, Sharp ZD, Weaker FJ, Kagan‐Hallet S., Story JL (1989) Proto‐oncogene analyses in brain tumors. J Neurosurg 70: 910–915. [DOI] [PubMed] [Google Scholar]
43. Fujimoto M., Weaker FJ, Herbert DC, Sharp ZD, Sheridan PJ, Story JL (1988) Expression of three viral oncogenes (v‐sis, v‐myc, v‐fos) in primary human brain tumors of neuroectodermal origin. Neurology 38: 289–293. [DOI] [PubMed] [Google Scholar]
44. Fuiler GN, Bigner SH (1992) Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Res 276: 299–306. [DOI] [PubMed] [Google Scholar]
45. Gammeltoft S., Ballotti R., Kowalski A., Westermark B., van Obberghen E. (1988) Expression of two types of receptor for insulin‐like growth factors in human malignant glioma. Cancer Res 48: 1233–1237. [PubMed] [Google Scholar]
46. Garson JA, Mclntyre PG, Kemshead JT (1985) N‐myc amDiification in malignant astrocytoma. Lancet 2: 718–719. [DOI] [PubMed] [Google Scholar]
47. Geddes JF, Vowles GH, Ashmore SM, Cockbum HA, Darling JL (1994) Detection of multidrug resistance gene product (P‐glycoprotein) expression in ependymomas. Neuropathol App Neurobiol 20: 118–121. [DOI] [PubMed] [Google Scholar]
48. Gerszten PC, Pollack IF, Martinez AJ, Lo KH, Janosky J., Albright AL (1996) Intracranial ependymomas of childhood—lack of correlation of histopathology and clinical outcome. Pathol Res Prac 192: 515–522. [DOI] [PubMed] [Google Scholar]
49. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P., Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, et ai. (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin One 12: 1607–1615. [DOI] [PubMed] [Google Scholar]
50. Gilies FH, Sobel EL, Tavare CJ, Leviton A., Hedley‐Whyte ET (1995) Age‐related changes in diagnoses, histological features, and survival in children with brain tumors: 1930–1979. The Childhood Brain Tumor Consortium. Neurosurgery 37: 1056–1068. [DOI] [PubMed] [Google Scholar]
51. Goldwein JW, Glauser TA, Packer RJ, Finiay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L., D'Angio GJ (1990) Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66: 557–563. [DOI] [PubMed] [Google Scholar]
52. Greenlee JE, Becker LE, Narayan O., Johnson RT (1978) Failure to demonstrate papovaviras turner antigen in human cerebral neoplasms. Ann Neurol 3: 479–481. [DOI] [PubMed] [Google Scholar]
53. Griffin CA, Long PP, Carson BS, Brem H. (1992) Chromosome abnormalities in low‐grade central nervous system tumors. Cancer Genet Cytognet 60: 67–73. [DOI] [PubMed] [Google Scholar]
54. Guha A. (1991) Platelet‐derved growth factor: a genera review with emohasis on astrocytomas. Pediatr Neurosurg 17: 14–20. [DOI] [PubMed] [Google Scholar]
55. Hall WA, Merrill MJ, Walbridge S., Youle RJ (1990) Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg 72: 641–646. [DOI] [PubMed] [Google Scholar]
56. Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ (1991) The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28: 666–671; discussion 671–662. [DOI] [PubMed] [Google Scholar]
57. Hoang‐Xuan K., Merel P., Vega F., Hugot JP, Corna P., Delattre JY, Poisson M., Thomas G., Delattre O. (1995) Analysis of the NF2 tumor‐suporesscr gene and of enromosome 22 deletions in gliomas Int J Cancer 60: 478–481. [DOI] [PubMed] [Google Scholar]
58. Hoshino D. (1984) A commentary on the biology and growtn kinetics of low‐grade and high‐grade gliomas. J Neurosurg 61: 895–900. [DOI] [PubMed] [Google Scholar]
59. Ikezaki K., Matsushima T., Inoue T., Yokoyama N. Kaneko Y., Fukui M. (1993) Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 32: 38–44. [DOI] [PubMed] [Google Scholar]
60. James CD, Carlbom E., Dumanski JP, Hansen M., Nordenskjold M., Collins VP, Cavenee WK (1988) Clonal genemic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551. [PubMed] [Google Scholar]
61. James CD, He J., Caribom E., Mikkeisen T. Ridderhelm PA, Cavenee WK, Collins VP (1990) Loss of genetic information in cental nervous system tumors common to children and young adults. Genes Chromos Cancer 2: 94–102. [DOI] [PubMed] [Google Scholar]
62. James CD, Mikkelsen T., Cavenee WK, Collins VP (1990) Molecular genetic aspects of glial tumour evolution. Cancer Surveys 9: 631–644. [PubMed] [Google Scholar]
63. Jayawickreme DP, Hayward RD, Harness WF (1995) Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years. Childs Nerv Syst 11: 409–413. [DOI] [PubMed] [Google Scholar]
64. Jenkins RB, Kimme DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW (1989) A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39: 253–279. [DOI] [PubMed] [Google Scholar]
65. Karamitopoulou E., Perentes E., Marazictis T. (1994) Ki‐67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87: 47–54. [DOI] [PubMed] [Google Scholar]
66. Karga HJ, Alexander JM, Hedley‐Whyte ET Klibanski A., Jameson JL (1992) Ras mutations in human pituitary tumors. J Clin Endocrinol Metabl 74: 914–919. [DOI] [PubMed] [Google Scholar]
67. Karlbom AE, James CD, Boethius J., Cavenee WK, Collins VP, Nordenskjold M., Larsson C. (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions en chromosome 10. Human Genetics 92: 169–174. [DOI] [PubMed] [Google Scholar]
68. Kernchan J., Sayre G. (1952) Tumors of the centra: nervous system. Atlas of tumor pathology, Section X, Fascicles 35 and 37, Armed Forces institute of Pathology: Washington DC . [Google Scholar]
69. Khalid H., Yasunaga A., Kishikawa M., Shibata S. (1995) Immunohistcchemical expression of the estrogen receptor‐related antigen (ER‐D5) in human intracranial tumors. Cancer 75: 2571–2578. [DOI] [PubMed] [Google Scholar]
70. King P., Cooper PN, Malcolm AJ (1993) Soft tissue ependymoma: a report of three cases. Histopathology 22: 394–396. [DOI] [PubMed] [Google Scholar]
71. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70–73. [DOI] [PubMed] [Google Scholar]
72. Kirschstein R., Gerber P. (1962) Ependymomas produced after intracerebral innoculation of SV40 into new‐born hamsters. Nature 195: 299–300. [DOI] [PubMed] [Google Scholar]
73. Kleihues P., Burger P., Scheithauer B. (1993) The new WHO classification of brain tumors. Brain Pathol 3: 255–268. [DOI] [PubMed] [Google Scholar]
74. Kordek R., Hironishi M., Liberski PP, Yanagihara R., Gajdusek DC (1996) Apoptosis in glial tumors as determined by in situ nonradioactive labeling of DNA breaks. Acta Neuropathol 91: 112–116. [DOI] [PubMed] [Google Scholar]
75. Kosaka H., Sano Y., Matsukado Y., Sairenji T., Hinuma Y. (1980) Failure to detect papovavirus‐associated T antigens in human brain tumor cells by anticomplement immunofluorescence. J Neurosurg 52: 367–370. [DOI] [PubMed] [Google Scholar]
76. Kovalic JJ, Flaris N., Grigsby PW, Pirkowski M., Simpson JR, Roth KA (1993) Intracranial ependymoma long‐term outcome, patterns of failure. J Neuro-Onc 15: 125–131. [DOI] [PubMed] [Google Scholar]
77. Krainer M., Schenk T., Zielinski CC, Muller C. (1995) Failure to confirm presence of SV40 sequences in human tumours. Eur J Cancer 31A: 1893. [DOI] [PubMed] [Google Scholar]
78. Krontiris TG, DiMartino NA, Colb M., Parkinson DR (1985) Unique allelic restriction fragments of the human Ha‐ras locus in leukocyte and tumour DNAs of cancer patients. Nature 313: 369–374. [DOI] [PubMed] [Google Scholar]
79. Kum W., Cockram CS, Zhu SQ, Teoh R., Young JD (1989) Insulin binding to human astrocytoma cells and its effect on uridine incorporation into nucleic acid. J Neurochem 52: 242–247. [DOI] [PubMed] [Google Scholar]
80. Landis CA, Harsh G., Lyons J., Davis RL, McCormick F., Bourne HR (1990) Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 71: 1416–1420. [DOI] [PubMed] [Google Scholar]
81. Landis CA, Masters SB, Spada A., Pace AM, Bourne HR, Vallar L. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696. [DOI] [PubMed] [Google Scholar]
82. Leach FS, Tokino T., Meltzer P., Burrell M., Oliner JD, Smith S., Hill DE, Sidransky D., Kinzler KW, Vogelstein B. (1993) p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231–2234. [PubMed] [Google Scholar]
83. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS (1995) Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 2: 710–717. [DOI] [PubMed] [Google Scholar]
84. Lee M., Rezai AR, Freed D., Epstein FJ (1996) Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 38: 32–37. [DOI] [PubMed] [Google Scholar]
85. Louis D., Ramesh V., Gusella J. (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5: 163–172. [DOI] [PubMed] [Google Scholar]
86. Lyons MK, Kelly PJ (1991) Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28: 659–664. [PubMed] [Google Scholar]
87. Matsumoto T., Tani E., Kaba K., Shindo H., Miyaji K. (1991) Expression of P‐glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg 74: 460–466. [DOI] [PubMed] [Google Scholar]
88. Meinke W., Goldstein DA, Smith RA (1979) Simian virus 40‐related DNA sequences in a human brain tumor. Neurology 29: 1590–1594. [DOI] [PubMed] [Google Scholar]
89. Metzger AK, Sheffield VC, Duyk G., Daneshvar L., Edwards MS, Cogen PH (1991) Identification of a germline mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci USA 88: 7825–7829. [DOI] [PMC free article] [PubMed] [Google Scholar]
90. Mikkelsen T., Cairncross JG, Cavenee WK (1991) Genetics of the malignant progression of astrocytoma. J Cell Biochem 46: 3–8. [DOI] [PubMed] [Google Scholar]
91. Milner J., Medcalf E. (1991) Cotranslation of activated mutant p53 with wild type drives the wild‐type p53 protein into the mutant conformation. Cell 65: 765–774. [DOI] [PubMed] [Google Scholar]
92. Mineura K., Izumi I., Kuwahara N., Kowada M. (1994) 06‐methylguanine‐DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment Acta Oncologica 33: 29–32. [DOI] [PubMed] [Google Scholar]
93. Mork SJ, Loken AC (1977) Ependymoma: a follow‐up study of 101 cases. Cancer 40: 907–915. [DOI] [PubMed] [Google Scholar]
94. Muller HL, Oh Y., Gargosky SE, Lehmbecher T., Hintz RL, Rosenfeld RG (1993) Concentrations of insulin‐like growth factor (IGF)‐binding protein‐3 (IGFBP‐3), IGF, and IGFBP‐3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 77: 1113–1119. [DOI] [PubMed] [Google Scholar]
95. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Phillips PC, Grossman SA, Brem H., Colvin OM (1991) Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 75: 941–946. [DOI] [PubMed] [Google Scholar]
96. Nagashima T., Hoshino T., Cho KG, Edwards MS, Hudgins RJ, Davis RL (1988) The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61: 2433–2438. [DOI] [PubMed] [Google Scholar]
97. Nazar GB, Hoffman HJ, Becker LE, Jenkin D., Humphreys RP, Hendrick EB (1990) Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72: 408–417. [DOI] [PubMed] [Google Scholar]
98. Neumann E., Kalousek DK, Norman MG, Steinbok P., Cochrane DD, Goddard K. (1993) Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71: 40–49. [DOI] [PubMed] [Google Scholar]
99. Newcomb EW, Madonia WJ, Pisharody S., Lang FF, Koslow M., Miller DC (1993) A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3: 229–235. [DOI] [PubMed] [Google Scholar]
100. Nijssen PC, Deprez RH, Tijssen CC, Hagemeijer A., Arnoldus EP, Teepen JL, Holl R., Niermeyer MF (1994) Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neurol Neurosurg Psychiat 57: 1245–1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
101. Nister M., Libermann TA, Betsholtz C., Pettersson M., Claesson‐Welsh L., Heldin CH, Schlessinger J., Westermark B. (1988) Expression of messenger RNAs for platelet‐derived growth factor and transforming growth factor‐alpha and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910–3918. [PubMed] [Google Scholar]
102. Ohgaki H., Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P. (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202–6205. [PubMed] [Google Scholar]
103. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. (1992) Amplification of a gene encoding a p53‐associated protein in human sarcomas. Nature 358: 80–83. [DOI] [PubMed] [Google Scholar]
104. Palma L., Celli P., Cantore G. (1993) Supratentorial ependymomas of tha first two decades of life. Long‐term follow‐up of 20 cases (inducing two subependymomas). Neurosurgery 22: 169–175. [DOI] [PubMed] [Google Scholar]
105. Paoetti P., Butti G., Zbera C., Scerratl M., Gibelli N., Roseilli R., Magrassi L., Sica G., Rossi G., Robusteili della Cuna G. (1990) Characteristics and biological role of steroid hormone receptors in neuroepithelial tumors. J Neurosurg 73: 736–742. [DOI] [PubMed] [Google Scholar]
106. Papadopoulos DP, Giri S., Evans RG (1990) Prognostic factors and management of intracranial ependymomas. Anticancer Res 10: 689–692. [PubMed] [Google Scholar]
107. Park JP, Chaffee S., Noll WW, Rhodes CH (1996) Constitutional de novo t(1;22)(p22;q11.2) and ependymoma. Cancer Genet Cytogenet 86: 150–152. [DOI] [PubMed] [Google Scholar]
108. Paulus W., Grothe C., Sensenbrenner M., Janet T., Baur I., Graf M., Roggendorf W. (1990) Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol 79: 418–423. [DOI] [PubMed] [Google Scholar]
109. Pershouse MA, Stubblefield E., Hadi A., Kiliary AM, Yung WK, Steck PA (1993) Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53: 5043–5050. [PubMed] [Google Scholar]
110. Pollack IF (1994) Brain tumors in children. N Engl J Med 331: 1500–1507. [DOI] [PubMed] [Google Scholar]
111. Pollack IF, Gerszten PC, Vlartinez AJ, Lo KH, Shultz B., Albright AL, Janosky J., Deutsch M. (1995) Intracranial ependymomas of childhood: long‐term outcome and prognostic factors. Neurosurgery 37: 655–666. [DOI] [PubMed] [Google Scholar]
112. Raffel C. (1996) Molecular biology of pediatric gliomas. J Neuro-Oncol 28: 121–128. [DOI] [PubMed] [Google Scholar]
113. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB (1992) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromos Cancer 5: 348–356. [DOI] [PubMed] [Google Scholar]
114. Rasheed BK, Bigner SH (1991) Genetic alterations in glioma and meduloblastoma. Cancer Metast Rev 10: 289–299. [DOI] [PubMed] [Google Scholar]
115. Read G. (1984) The treatment of ependymoma of the brain or spinal canal by radiotherapy: a report of 79 cases. Clin Radiol 35: 163–166. [DOI] [PubMed] [Google Scholar]
116. Reifenberger G., Lie L., Ichimura K., Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM12 gene in a subset of human malignant gilomas without p53 mutations. Cancer Res 53: 2736–2739. [PubMed] [Google Scholar]
117. Reifenberger G., Reifenberger J., Ichimura K., Meltzer PS, Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13–14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54: 4299–4303. [PubMed] [Google Scholar]
118. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S. (1987) Chromosomal composition of a series of 22 human low‐grade gliomas. Cancer Genet Cytogenet 29: 223–237. [DOI] [PubMed] [Google Scholar]
119. Reyes‐Muglca M., Chou PM, Myint MM, Ridaura‐Sanz C., Gonzalez‐Crussi F., Tomita T. (1994) Ependymomas in children: histologic and DNA‐flow cytometric study. Pediatr Pathol 14: 453–466. [DOI] [PubMed] [Google Scholar]
120. Rezai A., Woo HH, Lee M., Cohen H., Zagzag D., Epstein FJ (1996) Disseminated ependymomas of the central nervous system. J Neurosurg 85: 618–624. [DOI] [PubMed] [Google Scholar]
121. Rogatto SR, Casartelli C., Rainho CA, Barbieri‐Neto J. (1993) Chromosomes in the genesis and progression of ependymomas. Cancer Genet Cytogenet 69: 146–152. [DOI] [PubMed] [Google Scholar]
122. Romic Stojkovic R., Grcevc N., Gamulin S. (1990) Sex steroid receptors in intracranial tumors. Cancer 65: 1968–1970. [DOI] [PubMed] [Google Scholar]
123. Rorke L., Gilles F., Davis R., Becker L. (1985) Revision of the World Health Organization classification of brain tumors. Cancer 56: 1869–1886. [DOI] [PubMed] [Google Scholar]
124. Rorke LB (1987) Relationship of morphology of ependymoma in children to prognosis. Prog Exp Temor Res 30: 170–174. [DOI] [PubMed] [Google Scholar]
125. Ross GW, Rubinstein LJ (1989) Lack of histopathologica correlation of malignant ependymomas with postocerative survival. J Neurosurg 70: 31–36. [DOI] [PubMed] [Google Scholar]
126. Rouleau G., Merel P., Lutchman M., Sanson V., Zucman J., Marineau C., Hoang X., Demczuk S., Dosmaze C., Plougastel B., Pulst S., Biljsma E., Fashold R., Dumanski J., de Jong P., Parry D., Eldridge R., Auras A., Delattre O. (1993) Alteration in a new gene encoding a putative membrane‐organizing protein causes neurofipromatosis type 2. Nature 363: 515–521. [DOI] [PubMed] [Google Scholar]
127. Rousseau P., Habrand JL, Sarrazin D., Kaifa C., Terrier‐Lacombe MJ, Rekacewicz C., Rey A. (1994) Treatment of intracranial ependymomas of children: review of a 15‐year experience. Int J Radiat Oncol Biol Phys 28: 381–386. [DOI] [PubMed] [Google Scholar]
128. Rubinstein L. (1972) Tumors of the central nervous system. Atlas of tumor pathology, 2nd series. Fascicle 6, Armed Forces Institute of Pathology: Washington DC . [Google Scholar]
129. Rublo MP, Correa KM, Ramesn V., MacCollin MM, Jacooy LB, von Deimling A., Gusella JF, Louis DN (1994) Analysis of tne neurofibromatosis 2 gene in uuman ependymomas and astrocytomas. Cancer Res 54; 45–47. [PubMed] [Google Scholar]
130. Rubio MP, von Deimling A., Yande DW, Wiestler OD, Gusella JF, Louis DN (1993) Accumuiation of wild‐tyce p53 protein in human astrocytomas. Career Res 53: 3465–3467. [PubMed] [Google Scholar]
131. Sainati L., Montaldi A., Puttl MC, Giangaspera F., Rigebello L., Steila M., Zanesco L., Basso G. (1992) Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas Cancer Genet Cytogenet 59: 213–216. [DOI] [PubMed] [Google Scholar]
132. Salazar OM, Rubin P., Bassano D., Marcia VA (1975) Improved survival of patients with intracranial epencymomas by irradiation: dose selection and field extension. Cancer 35: 1563–1573. [DOI] [PubMed] [Google Scholar]
133. Salgalier M., Agius L., Yates A., Pearl D., Roberts W., Stephens R. (1990) Application of automated image anal ysis to demonstrate the correlation between, ras p21 expression and severity of gliomas. Biochem Biophysic Res Com 169:482–491. [DOI] [PubMed] [Google Scholar]
134. Salgalier M., Pearl D., Stephens R. (1991) In situ hybridization with single‐stranded RNA probes to demonstrate infrequently elevated gli mRNA and no increased ras mRNA levels in meningiomas and astrocytomas Cancer Letters 57: 243–253. [DOI] [PubMed] [Google Scholar]
135. Samuels V., Barrett JM, Bockman S., Pantazis CG, Allen MB, Jr. (1989) Immonocytochemical study of transforming growth factor expression, in benign and malignant gliomas. Am J Pathol 134: 894–902. [PMC free article] [PubMed] [Google Scholar]
136. Sato T., Shimoda A., Takahashi T., Kurokawa H., Arco M., Goto S., Takamura H. (1984) Congenital anaplastic ependymoma: a case report of famlliai giloma. Childs Brain 11: 342–348. [DOI] [PubMed] [Google Scholar]
137. Savard ML, Gilchrist DM (1989) Eoendymomas in two sisters and a maternal male cousin with mosaicism with monosomy 22 in tumour. Pediatr Neuroscr 15: 80–84. [DOI] [PubMed] [Google Scholar]
138. Sawyer JR, Sammartino G., Husain M., Boop FA, Chadduck WM (1994) Chromosome aberrations in four ependymomas. Cancer Genet Cytogenet 74: 132–138. [DOI] [PubMed] [Google Scholar]
139. Saxena A., Clark WC, Robertson JT, Ikejiri B., Oldfield EH, Ali IU (1992) Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 52: 6716–6721. [PubMed] [Google Scholar]
140. Scheurlen WG, Senf L. (1995) Analysis of the GAP‐related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors. Int J Cancer 64: 234–238. [DOI] [PubMed] [Google Scholar]
141. Schiffer D., Chio A., Cravioto H., Giordana MT, Migheli A., Soffietti R., Vigliani MC (1991) Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery 29: 206–210. [PubMed] [Google Scholar]
142. Schiffer D., Chio A., Giordana MT, Migheli A., Palma L., Pollo B., Soffietti R., Tribolo A. (1991) Histologic prognostic factors in ependymoma. Childs Nerv Syst 7: 177–182. [DOI] [PubMed] [Google Scholar]
143. Schroder R., Ploner C., Ernestus RI (1993) The growth potential of ependymomas with varying grades of malignancy measured by the Ki‐67 labelling index and mitotic index. Neurosurg Rev 16: 145–150. [DOI] [PubMed] [Google Scholar]
144. Seeger RC, Brodeur GM, Sather H., Dalton A., Siegel SE, Wong KY, Hammond D. (1985) Association of multiple copies of the N‐myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111–1116. [DOI] [PubMed] [Google Scholar]
145. Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD (1987) Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13: 1457–1462. [DOI] [PubMed] [Google Scholar]
146. Shuman RM, Alvord EC, Jr. , Leech RW (1975) The biology of childhood ependymomas. Arch Neurol 32: 731–739. [DOI] [PubMed] [Google Scholar]
147. Sieb JP, Pulst SM, Buch A. (1992) Familial CNS tumors. J Neurol 239: 343–344. [DOI] [PubMed] [Google Scholar]
148. Silber JR, Mueller BA, Ewers TG, Berger MS (1993) Comparison of 06‐methylguanine‐DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53: 3416–3420. [PubMed] [Google Scholar]
149. Slave I., MacCollin MM, Dunn M., Jones S., Sutton L., Gusella JF, Biegel JA (1995) Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64: 243–247. [DOI] [PubMed] [Google Scholar]
150. Steck PA, Ligon AH, Cheong P., Yung WK, Pershouse MA (1995) Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromes Cancer 12: 255–261. [DOI] [PubMed] [Google Scholar]
151. Steinbok P., Hentschel S., Cochrane DD, Kestle JR (1996) Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84: 726–732. [DOI] [PubMed] [Google Scholar]
152. Stratton MR, Darling J., Lantos PL, Cooper CS, Reeves BR (1989) Cytogenetic abnormalities in human ependymomas. Int J Cancer 44: 579–581. [DOI] [PubMed] [Google Scholar]
153. Sutton LN, Goldwein J., Perilongo G., Lang B., Schut L., Rorke L., Packer R. (1990) Prognostic factors in childhood ependymomas. Pediatr Neurosurg 16: 57–65. [DOI] [PubMed] [Google Scholar]
154. Thapar K., Fukuyama K., Rutka J. (1995) Neurogenetics and the molecular biology of human brain tumors. In: Brain Tumors, Kaye A., Laws E. Jr. (eds.), pp. 69–97, Churchill Livingstone: New York , NY . [Google Scholar]
155. Thiel G., Marczinek K., Neumann R., Witkowski R., Marchuk DA, Nurnberg P. (1995) Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours. Anticancer Res 15: 2495–2499. [PubMed] [Google Scholar]
156. Tominaga T., Kayama T., Kumabe T., Sonoda Y., Yoshimoto T. (1995) Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis. Acta Neurochir 135: 163–170. [DOI] [PubMed] [Google Scholar]
157. Torp SH, Helseth E., Ryan L., Stolan S., Dalen A., Unsgaard G. (1991) Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res 11: 2095–2098. [PubMed] [Google Scholar]
158. Trent J., Meltzer P., Rosenblum M., Harsh G., Kinzler K., Mashal R., Feinberg A., Vogelstein B. (1986) Evidence for rearrangement, amplification, and expression of c‐myc in a human glioblastoma. Proc Natl Acad Sci USA 83: 470–473. [DOI] [PMC free article] [PubMed] [Google Scholar]
159. Ueki K., Rubio MP, Ramesh V., Correa KM, Rutter JL, von Deimling A., Buckler AJ, Gusella JF, Louis DN (1994) MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3: 1841–1845. [DOI] [PubMed] [Google Scholar]
160. Undjian S., Marinov M. (1990) Intracranial ependymomas in children. Childs Nerv Syst 6: 131–134. [DOI] [PubMed] [Google Scholar]
161. Vagner‐Capodano AM, Gentet JC, Gambarelli D., Pellissier JF, Gouzien M., Lena G., Genitori L., Choux M., Raybaud C. (1992) Cytogenetic studies in 45 pediatric brain tumors. Pediatr Hematol Oncol 9: 223–235. [DOI] [PubMed] [Google Scholar]
162. Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M. (1992) Intracranial ependymoma: long‐term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 23: 313–319. [DOI] [PubMed] [Google Scholar]
163. von Schoultz E., Bixo M., Backstrom T., Silfvenius H., Wilking N., Henriksson R. (1990) Sex steroids in human brain tumors and breast cancer. Cancer 65: 949–952. [DOI] [PubMed] [Google Scholar]
164. Vonhaken MS White EC, Daneshvarshyesther L., Sih S., Choi E., Kalra R., Cogen PH (1996) Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic ependymomas. Genes Chromes Cancer 17: 37–44. [DOI] [PubMed] [Google Scholar]
165. Waha A., Baumann A., Wolf HK, Fimmers R., Neumann J., Kindermann D., Astrahantseff K., Blumcke I., Vondeimling A., Schlegel U. (1996) Lack of prognostic relevance of alterations in the epidermal growth factor receptor transforming growth factor‐alpha pathway in human astrocytic gliomas. J Neurosurg 85: 634–641. [DOI] [PubMed] [Google Scholar]
166. Wasson JC, Saylors RLd, Zeltzer P., Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM (1990) Oncogene amplification in pediatric brain tumors, Cancer Res 50: 2987–2990. [PubMed] [Google Scholar]
167. Weitman SD, Frazier KM, Kamen BA (1994) The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncol 21: 107–112. [DOI] [PubMed] [Google Scholar]
168. Weremowicz S., Kupsky WJ, Morton CC, Fletcher JA (1992) Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytognet 61: 193–196. [DOI] [PubMed] [Google Scholar]
169. Wernicke C., Thiel G., Lozanova T., Vogel S., Kintzel D., Janisch W., Lehmann K., Witkowski R. (1995) Involvement of chromosome 22 in ependymomas. Cancer Genet Cytognet 79: 173–176. [DOI] [PubMed] [Google Scholar]
170. West C. (1985) Ependymomas: factors in clinical and diagnostic staging. Cancer 56: 1812–1816. [DOI] [PubMed] [Google Scholar]
171. Westermark B., Nister M. (1995) Molecular genetics of human glioma. Curr Op Oncol 7: 220–225. [DOI] [PubMed] [Google Scholar]
172. Wold WS, Mackey JK, Brackmann KH, Takemori N., Rigden P., Green M. (1978) Analysis of human tumors and human malignant cell lines for BK virus‐specific DNA sequences. Proc Natl Acad Sci USA 75: 454–458. [DOI] [PMC free article] [PubMed] [Google Scholar]
173. Wong AJ, Signer SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899–6903. [DOI] [PMC free article] [PubMed] [Google Scholar]
174. Wu JK, Chikaraishi DM (1990) Differential expression, of mos oncogene in primary human astrocytomas and astrocytoma cell lines. Cancer Res 50: 3032–3035. [PubMed] [Google Scholar]
175. Wullich B., Muller HW, Fischer U., Zang KD, Meese E. (1993) Amplified met gene linked to double minutes in human glioblastoma. Eur J Cancer 29A: 1991–1995. [DOI] [PubMed] [Google Scholar]
176. Wullich B., Sattler HP, Fischer U., Meese E. (1994) Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14: 577–579. [PubMed] [Google Scholar]
177. Zagzag D., Miller DC, Sato Y., Rifkin DB, Burster, DE (1990) Immunohistochemical localization of basic flbroblast growth factor in astrocytomas. Cancer Res 50: 7393–7398. [PubMed] [Google Scholar]

[b1] 1. Afra D., Muller W., Slowik F., Wilcke O., Budka H., Turoczy L. (1983) Supratentoriai lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir 69: 243–251. [DOI] [PubMed] [Google Scholar]

[b2] 2. Antonlades HN, Galanopolos T., Noville‐Golden J., Maxwell M. (1992) Expression of insulinlike growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50: 215–222. [DOI] [PubMed] [Google Scholar]

[b3] 3. Arnoldus EP, Wolters LB, Voormolen JH, van Duinen SG, Raap AK, van der Ploeg M., Peters AC (1992) Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. J Neurosurg 76: 997–1003. [DOI] [PubMed] [Google Scholar]

[b4] 4. Asai A., Hoshino T., Edwards MS, Davis RL (1992) Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv Syst 8: 273–278. [DOI] [PubMed] [Google Scholar]

[b5] 5. Awaad YM, Allen JC, Miller DC, Schneider SJ, Wisoff J. Epstein FJ (1996) Deferring adjuvant therapy for totally resected intracranial ependymoma. Ped Neurol 14: 216–219. [DOI] [PubMed] [Google Scholar]

[b6] 6. Barone BM, Elvidge AR (1970) Ependymomas. A clinical survey. J Neurosurg 33: 428–438. [DOI] [PubMed] [Google Scholar]

[b7] 7. Becker I., Becker KF, Meyermann R., Hollt V. (1991) The multidrug‐resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82: 516–519. [DOI] [PubMed] [Google Scholar]

[b8] 8. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Eng J Med 326: 988–993. [DOI] [PubMed] [Google Scholar]

[b9] 9. Bigner SH, Wong AJ, Mark J., Muhlbaier LH, Kinzler KW, Vogelstein B., Bigner DD (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29: 165–170. [DOI] [PubMed] [Google Scholar]

[b10] 10. Bijlsma EK, Voesten AM, Bijleveld EH, Troost D., Westerveld A., Merel P., Thomas G., Hulsebos TJ (1995) Molecular analysis of genetic changes in ependymomas. Genes Chromosom Cancer 13: 272–277. [DOI] [PubMed] [Google Scholar]

[b11] 11. Bloom HJ, Glees J., Bell J., Ashley SE, Gorman C. (1990) The treatment and long‐term prognosis of children with intracranial tumors: a study of 610 cases, 1950–1981. Int J Radiat Oncol Biol Phys 18: 723–745. [DOI] [PubMed] [Google Scholar]

[b12] 12. Brodeur GM, Seeger RC, Schwab M., Varmus HE, Bishop JM (1984) Amplification of N‐myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124. [DOI] [PubMed] [Google Scholar]

[b13] 13. Burger P., Scheithauer B. (1994) Tumors of the central nervous system. Atlas of tumor pathology 3rd series, Fascicle 10, Armed Forces Institute of Pathology: Washington DC . [Google Scholar]

[b14] 14. Chiu JK, Woo SY, Ater J., Connelly J., Bruner JM, Maor MH, van Eys J., Oswald MJ, Shallenberger R. (1992) Intracranial ependymoma in children: analysis of prognostic factors. J Neuro-onc 13: 283–290. [DOI] [PubMed] [Google Scholar]

[b15] 15. Chou PM, Barquin N., Gonzalezcrussi F., Sanz CR, Tomita T., Reyesmugica M. (1996) Ependymomas in children express the multidrug resistance gene immunohistochemical and molecular biologic study. Ped Pathol Lab Med 16: 551–561. [PubMed] [Google Scholar]

[b16] 16. Cogen PH (1991) Prognostic significance of molecular genetic markers in childhood brain tumors. Ped Neurosurg 17: 245–250. [DOI] [PubMed] [Google Scholar]

[b17] 17. Cogen PH, Daneshvar L., Metzger AK, Duyk G., Edwards MS, Sheffield VC (1992) Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Med Genet 50: 584–589. [PMC free article] [PubMed] [Google Scholar]

[b18] 18. Collins VP, James CD (1993) Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7: 926–930. [DOI] [PubMed] [Google Scholar]

[b19] 19. Corallini A., Pagnani M., Viadana P., Silini E., Mottes M., Milanesi G., Gerna G., Vettor R., Trapella G., Silvani V., et al. (1987) Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer 39: 60–67. [DOI] [PubMed] [Google Scholar]

[b20] 20. Coulon RA, Till K. (1977) Intracranial ependymomas in children: a review of 43 cases. Childs Brain 3: 154–168. [PubMed] [Google Scholar]

[b21] 21. Dal Cin P., Sandberg AA (1988) Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 30: 289–293. [DOI] [PubMed] [Google Scholar]

[b22] 22. Debiec‐Rychter M., Lasota J., Alwasiak J., Liberski PP (1995) Recurrent anaplastic ependymoma with an abnormal karyotype and c‐myc proto‐oncogene overexpression. Acta Neuropathol 89: 270–274. [DOI] [PubMed] [Google Scholar]

[b23] 23. DeMonte F., Al‐Mefty O. (1995) Meningiomas. In: Brain Tumors, Kaye A., Laws E. Jr. (eds.), pp. 675–704, Churchill Livingstone: New York , NY . [Google Scholar]

[b24] 24. Diedrich U., Eckermann O., Schmidtke J. (1988) Rare Haras and c‐mos alleles in patients with intracranial tumors. Neurology 38: 587–589. [DOI] [PubMed] [Google Scholar]

[b25] 25. Diedrich U., Soja S., Behnke J., Zoll B. (1991) Amplification of the c‐erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue. J Neurol 238: 221–224. [DOI] [PubMed] [Google Scholar]

[b26] 26. Dohrmann GJ, Farwell JR, Flannery JT (1976) Ependymomas and ependymoblastomas in children. J Neurosurg 45: 273–283. [DOI] [PubMed] [Google Scholar]

[b27] 27. Duffner P., Cohen M., Voorhess M., MacGillivray M., Brecher M., Panahon A., Gilani B. (1985) Long‐term effects of cranial irradiation on endocrine function in children with brain tumors: a prospective study. Cancer 56: 2189–2193. [DOI] [PubMed] [Google Scholar]

[b28] 28. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, et al. (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Eng J Med 328: 1725–1731. [DOI] [PubMed] [Google Scholar]

[b29] 29. Dumanski JP, Rouleau GA, Nordenskjold M., Collins VP (1990) Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863–5867. [PubMed] [Google Scholar]

[b30] 30. Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH (1992) Spinal MR findings in neurofibromatosis types 1 and 2 . Am J Neuradiol 13: 1071–1077. [PMC free article] [PubMed] [Google Scholar]

[b31] 31. Ekstrand AJ, James CD, Cavenee WK, Seliger B., Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo . Cancer Res 51: 2164–2172. [PubMed] [Google Scholar]

[b32] 32. Ellenberg L. McComb J., Siegel S., Stowe S. (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurg 21: 638–644. [DOI] [PubMed] [Google Scholar]

[b33] 33. Ernestus RI, Schroder R., Stutzer H., Klug N. (1996) Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 12:522–526. [DOI] [PubMed] [Google Scholar]

[b34] 34. Ernestus RI. Wilcke O., Schroder R. (1989) Intracranial ependymomas: prognostic aspects. Neurosurg Rev 12: 157–163. [DOI] [PubMed] [Google Scholar]

[b35] 35. Ernestus RI, Wilcke O., Schroder R. (1991) Supratentorial ependymomas in childhood: clinicopathological findings and prognos s. Acta Neurochir 111: 96–102. [DOI] [PubMed] [Google Scholar]

[b36] 36. Evans AE, Anderson JR, Lefkowitz‐Boudreaux IB, Finlay JL (1996) Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio‐spinal irradiation with or without adjuvart CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediarr Oncol 27: 8–14. [DOI] [PubMed] [Google Scholar]

[b37] 37. Ferrante L., Mastronardi L., Schettini G., Lunardi P., Fortuna A. (1994) Fourth ventricle ependymomas. A study of 20 cases with survival analysis. Acta Neurochir 131: 67–74. [DOI] [PubMed] [Google Scholar]

[b38] 38. Figarella‐Branger D., Gambarelli D., Dollo C., Devictor B., Perez‐Castillo AM, Genitori L., Lena G., Choux M., Peilissier JF (1991) Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post‐operative survival in 16 cases. Acta Neuropathol 82: 208–216. [DOI] [PubMed] [Google Scholar]

[b39] 39. Figarella‐Branger D., Lepidi H., Poncet C., Gambarelli D., Bianco N., Rougon G., Pellissier JF (1995) Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors. Acta Neuropathol 89: 248–257. [DOI] [PubMed] [Google Scholar]

[b40] 40. Fink KL, Rushing EJ, Schold SC, Jr. , Nisen PD (1996) Infrequency of p53 gene mutations in ependymomas. J Neuro-Oncol 27: 111–115. [DOI] [PubMed] [Google Scholar]

[b41] 41. Friedman HS, Krischer JP, Burger P., Oakes WJ, Hockenberger B., Weiner MD, Falletta JM, Norris D., Ragab AH, Mahoney DH, Jr. , et al. (1992) Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10: 249–256. [DOI] [PubMed] [Google Scholar]

[b42] 42. Fujimoto M., Sheridan PJ, Sharp ZD, Weaker FJ, Kagan‐Hallet S., Story JL (1989) Proto‐oncogene analyses in brain tumors. J Neurosurg 70: 910–915. [DOI] [PubMed] [Google Scholar]

[b43] 43. Fujimoto M., Weaker FJ, Herbert DC, Sharp ZD, Sheridan PJ, Story JL (1988) Expression of three viral oncogenes (v‐sis, v‐myc, v‐fos) in primary human brain tumors of neuroectodermal origin. Neurology 38: 289–293. [DOI] [PubMed] [Google Scholar]

[b44] 44. Fuiler GN, Bigner SH (1992) Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Res 276: 299–306. [DOI] [PubMed] [Google Scholar]

[b45] 45. Gammeltoft S., Ballotti R., Kowalski A., Westermark B., van Obberghen E. (1988) Expression of two types of receptor for insulin‐like growth factors in human malignant glioma. Cancer Res 48: 1233–1237. [PubMed] [Google Scholar]

[b46] 46. Garson JA, Mclntyre PG, Kemshead JT (1985) N‐myc amDiification in malignant astrocytoma. Lancet 2: 718–719. [DOI] [PubMed] [Google Scholar]

[b47] 47. Geddes JF, Vowles GH, Ashmore SM, Cockbum HA, Darling JL (1994) Detection of multidrug resistance gene product (P‐glycoprotein) expression in ependymomas. Neuropathol App Neurobiol 20: 118–121. [DOI] [PubMed] [Google Scholar]

[b48] 48. Gerszten PC, Pollack IF, Martinez AJ, Lo KH, Janosky J., Albright AL (1996) Intracranial ependymomas of childhood—lack of correlation of histopathology and clinical outcome. Pathol Res Prac 192: 515–522. [DOI] [PubMed] [Google Scholar]

[b49] 49. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P., Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, et ai. (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin One 12: 1607–1615. [DOI] [PubMed] [Google Scholar]

[b50] 50. Gilies FH, Sobel EL, Tavare CJ, Leviton A., Hedley‐Whyte ET (1995) Age‐related changes in diagnoses, histological features, and survival in children with brain tumors: 1930–1979. The Childhood Brain Tumor Consortium. Neurosurgery 37: 1056–1068. [DOI] [PubMed] [Google Scholar]

[b51] 51. Goldwein JW, Glauser TA, Packer RJ, Finiay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L., D'Angio GJ (1990) Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66: 557–563. [DOI] [PubMed] [Google Scholar]

[b52] 52. Greenlee JE, Becker LE, Narayan O., Johnson RT (1978) Failure to demonstrate papovaviras turner antigen in human cerebral neoplasms. Ann Neurol 3: 479–481. [DOI] [PubMed] [Google Scholar]

[b53] 53. Griffin CA, Long PP, Carson BS, Brem H. (1992) Chromosome abnormalities in low‐grade central nervous system tumors. Cancer Genet Cytognet 60: 67–73. [DOI] [PubMed] [Google Scholar]

[b54] 54. Guha A. (1991) Platelet‐derved growth factor: a genera review with emohasis on astrocytomas. Pediatr Neurosurg 17: 14–20. [DOI] [PubMed] [Google Scholar]

[b55] 55. Hall WA, Merrill MJ, Walbridge S., Youle RJ (1990) Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg 72: 641–646. [DOI] [PubMed] [Google Scholar]

[b56] 56. Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ (1991) The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28: 666–671; discussion 671–662. [DOI] [PubMed] [Google Scholar]

[b57] 57. Hoang‐Xuan K., Merel P., Vega F., Hugot JP, Corna P., Delattre JY, Poisson M., Thomas G., Delattre O. (1995) Analysis of the NF2 tumor‐suporesscr gene and of enromosome 22 deletions in gliomas Int J Cancer 60: 478–481. [DOI] [PubMed] [Google Scholar]

[b58] 58. Hoshino D. (1984) A commentary on the biology and growtn kinetics of low‐grade and high‐grade gliomas. J Neurosurg 61: 895–900. [DOI] [PubMed] [Google Scholar]

[b59] 59. Ikezaki K., Matsushima T., Inoue T., Yokoyama N. Kaneko Y., Fukui M. (1993) Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 32: 38–44. [DOI] [PubMed] [Google Scholar]

[b60] 60. James CD, Carlbom E., Dumanski JP, Hansen M., Nordenskjold M., Collins VP, Cavenee WK (1988) Clonal genemic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551. [PubMed] [Google Scholar]

[b61] 61. James CD, He J., Caribom E., Mikkeisen T. Ridderhelm PA, Cavenee WK, Collins VP (1990) Loss of genetic information in cental nervous system tumors common to children and young adults. Genes Chromos Cancer 2: 94–102. [DOI] [PubMed] [Google Scholar]

[b62] 62. James CD, Mikkelsen T., Cavenee WK, Collins VP (1990) Molecular genetic aspects of glial tumour evolution. Cancer Surveys 9: 631–644. [PubMed] [Google Scholar]

[b63] 63. Jayawickreme DP, Hayward RD, Harness WF (1995) Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years. Childs Nerv Syst 11: 409–413. [DOI] [PubMed] [Google Scholar]

[b64] 64. Jenkins RB, Kimme DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW (1989) A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39: 253–279. [DOI] [PubMed] [Google Scholar]

[b65] 65. Karamitopoulou E., Perentes E., Marazictis T. (1994) Ki‐67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87: 47–54. [DOI] [PubMed] [Google Scholar]

[b66] 66. Karga HJ, Alexander JM, Hedley‐Whyte ET Klibanski A., Jameson JL (1992) Ras mutations in human pituitary tumors. J Clin Endocrinol Metabl 74: 914–919. [DOI] [PubMed] [Google Scholar]

[b67] 67. Karlbom AE, James CD, Boethius J., Cavenee WK, Collins VP, Nordenskjold M., Larsson C. (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions en chromosome 10. Human Genetics 92: 169–174. [DOI] [PubMed] [Google Scholar]

[b68] 68. Kernchan J., Sayre G. (1952) Tumors of the centra: nervous system. Atlas of tumor pathology, Section X, Fascicles 35 and 37, Armed Forces institute of Pathology: Washington DC . [Google Scholar]

[b69] 69. Khalid H., Yasunaga A., Kishikawa M., Shibata S. (1995) Immunohistcchemical expression of the estrogen receptor‐related antigen (ER‐D5) in human intracranial tumors. Cancer 75: 2571–2578. [DOI] [PubMed] [Google Scholar]

[b70] 70. King P., Cooper PN, Malcolm AJ (1993) Soft tissue ependymoma: a report of three cases. Histopathology 22: 394–396. [DOI] [PubMed] [Google Scholar]

[b71] 71. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70–73. [DOI] [PubMed] [Google Scholar]

[b72] 72. Kirschstein R., Gerber P. (1962) Ependymomas produced after intracerebral innoculation of SV40 into new‐born hamsters. Nature 195: 299–300. [DOI] [PubMed] [Google Scholar]

[b73] 73. Kleihues P., Burger P., Scheithauer B. (1993) The new WHO classification of brain tumors. Brain Pathol 3: 255–268. [DOI] [PubMed] [Google Scholar]

[b74] 74. Kordek R., Hironishi M., Liberski PP, Yanagihara R., Gajdusek DC (1996) Apoptosis in glial tumors as determined by in situ nonradioactive labeling of DNA breaks. Acta Neuropathol 91: 112–116. [DOI] [PubMed] [Google Scholar]

[b75] 75. Kosaka H., Sano Y., Matsukado Y., Sairenji T., Hinuma Y. (1980) Failure to detect papovavirus‐associated T antigens in human brain tumor cells by anticomplement immunofluorescence. J Neurosurg 52: 367–370. [DOI] [PubMed] [Google Scholar]

[b76] 76. Kovalic JJ, Flaris N., Grigsby PW, Pirkowski M., Simpson JR, Roth KA (1993) Intracranial ependymoma long‐term outcome, patterns of failure. J Neuro-Onc 15: 125–131. [DOI] [PubMed] [Google Scholar]

[b77] 77. Krainer M., Schenk T., Zielinski CC, Muller C. (1995) Failure to confirm presence of SV40 sequences in human tumours. Eur J Cancer 31A: 1893. [DOI] [PubMed] [Google Scholar]

[b78] 78. Krontiris TG, DiMartino NA, Colb M., Parkinson DR (1985) Unique allelic restriction fragments of the human Ha‐ras locus in leukocyte and tumour DNAs of cancer patients. Nature 313: 369–374. [DOI] [PubMed] [Google Scholar]

[b79] 79. Kum W., Cockram CS, Zhu SQ, Teoh R., Young JD (1989) Insulin binding to human astrocytoma cells and its effect on uridine incorporation into nucleic acid. J Neurochem 52: 242–247. [DOI] [PubMed] [Google Scholar]

[b80] 80. Landis CA, Harsh G., Lyons J., Davis RL, McCormick F., Bourne HR (1990) Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 71: 1416–1420. [DOI] [PubMed] [Google Scholar]

[b81] 81. Landis CA, Masters SB, Spada A., Pace AM, Bourne HR, Vallar L. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696. [DOI] [PubMed] [Google Scholar]

[b82] 82. Leach FS, Tokino T., Meltzer P., Burrell M., Oliner JD, Smith S., Hill DE, Sidransky D., Kinzler KW, Vogelstein B. (1993) p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231–2234. [PubMed] [Google Scholar]

[b83] 83. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS (1995) Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 2: 710–717. [DOI] [PubMed] [Google Scholar]

[b84] 84. Lee M., Rezai AR, Freed D., Epstein FJ (1996) Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 38: 32–37. [DOI] [PubMed] [Google Scholar]

[b85] 85. Louis D., Ramesh V., Gusella J. (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5: 163–172. [DOI] [PubMed] [Google Scholar]

[b86] 86. Lyons MK, Kelly PJ (1991) Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28: 659–664. [PubMed] [Google Scholar]

[b87] 87. Matsumoto T., Tani E., Kaba K., Shindo H., Miyaji K. (1991) Expression of P‐glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg 74: 460–466. [DOI] [PubMed] [Google Scholar]

[b88] 88. Meinke W., Goldstein DA, Smith RA (1979) Simian virus 40‐related DNA sequences in a human brain tumor. Neurology 29: 1590–1594. [DOI] [PubMed] [Google Scholar]

[b89] 89. Metzger AK, Sheffield VC, Duyk G., Daneshvar L., Edwards MS, Cogen PH (1991) Identification of a germline mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci USA 88: 7825–7829. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b90] 90. Mikkelsen T., Cairncross JG, Cavenee WK (1991) Genetics of the malignant progression of astrocytoma. J Cell Biochem 46: 3–8. [DOI] [PubMed] [Google Scholar]

[b91] 91. Milner J., Medcalf E. (1991) Cotranslation of activated mutant p53 with wild type drives the wild‐type p53 protein into the mutant conformation. Cell 65: 765–774. [DOI] [PubMed] [Google Scholar]

[b92] 92. Mineura K., Izumi I., Kuwahara N., Kowada M. (1994) 06‐methylguanine‐DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment Acta Oncologica 33: 29–32. [DOI] [PubMed] [Google Scholar]

[b93] 93. Mork SJ, Loken AC (1977) Ependymoma: a follow‐up study of 101 cases. Cancer 40: 907–915. [DOI] [PubMed] [Google Scholar]

[b94] 94. Muller HL, Oh Y., Gargosky SE, Lehmbecher T., Hintz RL, Rosenfeld RG (1993) Concentrations of insulin‐like growth factor (IGF)‐binding protein‐3 (IGFBP‐3), IGF, and IGFBP‐3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 77: 1113–1119. [DOI] [PubMed] [Google Scholar]

[b95] 95. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Phillips PC, Grossman SA, Brem H., Colvin OM (1991) Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 75: 941–946. [DOI] [PubMed] [Google Scholar]

[b96] 96. Nagashima T., Hoshino T., Cho KG, Edwards MS, Hudgins RJ, Davis RL (1988) The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61: 2433–2438. [DOI] [PubMed] [Google Scholar]

[b97] 97. Nazar GB, Hoffman HJ, Becker LE, Jenkin D., Humphreys RP, Hendrick EB (1990) Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72: 408–417. [DOI] [PubMed] [Google Scholar]

[b98] 98. Neumann E., Kalousek DK, Norman MG, Steinbok P., Cochrane DD, Goddard K. (1993) Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71: 40–49. [DOI] [PubMed] [Google Scholar]

[b99] 99. Newcomb EW, Madonia WJ, Pisharody S., Lang FF, Koslow M., Miller DC (1993) A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3: 229–235. [DOI] [PubMed] [Google Scholar]

[b100] 100. Nijssen PC, Deprez RH, Tijssen CC, Hagemeijer A., Arnoldus EP, Teepen JL, Holl R., Niermeyer MF (1994) Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neurol Neurosurg Psychiat 57: 1245–1248. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b101] 101. Nister M., Libermann TA, Betsholtz C., Pettersson M., Claesson‐Welsh L., Heldin CH, Schlessinger J., Westermark B. (1988) Expression of messenger RNAs for platelet‐derived growth factor and transforming growth factor‐alpha and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910–3918. [PubMed] [Google Scholar]

[b102] 102. Ohgaki H., Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P. (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202–6205. [PubMed] [Google Scholar]

[b103] 103. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. (1992) Amplification of a gene encoding a p53‐associated protein in human sarcomas. Nature 358: 80–83. [DOI] [PubMed] [Google Scholar]

[b104] 104. Palma L., Celli P., Cantore G. (1993) Supratentorial ependymomas of tha first two decades of life. Long‐term follow‐up of 20 cases (inducing two subependymomas). Neurosurgery 22: 169–175. [DOI] [PubMed] [Google Scholar]

[b105] 105. Paoetti P., Butti G., Zbera C., Scerratl M., Gibelli N., Roseilli R., Magrassi L., Sica G., Rossi G., Robusteili della Cuna G. (1990) Characteristics and biological role of steroid hormone receptors in neuroepithelial tumors. J Neurosurg 73: 736–742. [DOI] [PubMed] [Google Scholar]

[b106] 106. Papadopoulos DP, Giri S., Evans RG (1990) Prognostic factors and management of intracranial ependymomas. Anticancer Res 10: 689–692. [PubMed] [Google Scholar]

[b107] 107. Park JP, Chaffee S., Noll WW, Rhodes CH (1996) Constitutional de novo t(1;22)(p22;q11.2) and ependymoma. Cancer Genet Cytogenet 86: 150–152. [DOI] [PubMed] [Google Scholar]

[b108] 108. Paulus W., Grothe C., Sensenbrenner M., Janet T., Baur I., Graf M., Roggendorf W. (1990) Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol 79: 418–423. [DOI] [PubMed] [Google Scholar]

[b109] 109. Pershouse MA, Stubblefield E., Hadi A., Kiliary AM, Yung WK, Steck PA (1993) Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53: 5043–5050. [PubMed] [Google Scholar]

[b110] 110. Pollack IF (1994) Brain tumors in children. N Engl J Med 331: 1500–1507. [DOI] [PubMed] [Google Scholar]

[b111] 111. Pollack IF, Gerszten PC, Vlartinez AJ, Lo KH, Shultz B., Albright AL, Janosky J., Deutsch M. (1995) Intracranial ependymomas of childhood: long‐term outcome and prognostic factors. Neurosurgery 37: 655–666. [DOI] [PubMed] [Google Scholar]

[b112] 112. Raffel C. (1996) Molecular biology of pediatric gliomas. J Neuro-Oncol 28: 121–128. [DOI] [PubMed] [Google Scholar]

[b113] 113. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB (1992) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromos Cancer 5: 348–356. [DOI] [PubMed] [Google Scholar]

[b114] 114. Rasheed BK, Bigner SH (1991) Genetic alterations in glioma and meduloblastoma. Cancer Metast Rev 10: 289–299. [DOI] [PubMed] [Google Scholar]

[b115] 115. Read G. (1984) The treatment of ependymoma of the brain or spinal canal by radiotherapy: a report of 79 cases. Clin Radiol 35: 163–166. [DOI] [PubMed] [Google Scholar]

[b116] 116. Reifenberger G., Lie L., Ichimura K., Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM12 gene in a subset of human malignant gilomas without p53 mutations. Cancer Res 53: 2736–2739. [PubMed] [Google Scholar]

[b117] 117. Reifenberger G., Reifenberger J., Ichimura K., Meltzer PS, Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13–14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54: 4299–4303. [PubMed] [Google Scholar]

[b118] 118. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S. (1987) Chromosomal composition of a series of 22 human low‐grade gliomas. Cancer Genet Cytogenet 29: 223–237. [DOI] [PubMed] [Google Scholar]

[b119] 119. Reyes‐Muglca M., Chou PM, Myint MM, Ridaura‐Sanz C., Gonzalez‐Crussi F., Tomita T. (1994) Ependymomas in children: histologic and DNA‐flow cytometric study. Pediatr Pathol 14: 453–466. [DOI] [PubMed] [Google Scholar]

[b120] 120. Rezai A., Woo HH, Lee M., Cohen H., Zagzag D., Epstein FJ (1996) Disseminated ependymomas of the central nervous system. J Neurosurg 85: 618–624. [DOI] [PubMed] [Google Scholar]

[b121] 121. Rogatto SR, Casartelli C., Rainho CA, Barbieri‐Neto J. (1993) Chromosomes in the genesis and progression of ependymomas. Cancer Genet Cytogenet 69: 146–152. [DOI] [PubMed] [Google Scholar]

[b122] 122. Romic Stojkovic R., Grcevc N., Gamulin S. (1990) Sex steroid receptors in intracranial tumors. Cancer 65: 1968–1970. [DOI] [PubMed] [Google Scholar]

[b123] 123. Rorke L., Gilles F., Davis R., Becker L. (1985) Revision of the World Health Organization classification of brain tumors. Cancer 56: 1869–1886. [DOI] [PubMed] [Google Scholar]

[b124] 124. Rorke LB (1987) Relationship of morphology of ependymoma in children to prognosis. Prog Exp Temor Res 30: 170–174. [DOI] [PubMed] [Google Scholar]

[b125] 125. Ross GW, Rubinstein LJ (1989) Lack of histopathologica correlation of malignant ependymomas with postocerative survival. J Neurosurg 70: 31–36. [DOI] [PubMed] [Google Scholar]

[b126] 126. Rouleau G., Merel P., Lutchman M., Sanson V., Zucman J., Marineau C., Hoang X., Demczuk S., Dosmaze C., Plougastel B., Pulst S., Biljsma E., Fashold R., Dumanski J., de Jong P., Parry D., Eldridge R., Auras A., Delattre O. (1993) Alteration in a new gene encoding a putative membrane‐organizing protein causes neurofipromatosis type 2. Nature 363: 515–521. [DOI] [PubMed] [Google Scholar]

[b127] 127. Rousseau P., Habrand JL, Sarrazin D., Kaifa C., Terrier‐Lacombe MJ, Rekacewicz C., Rey A. (1994) Treatment of intracranial ependymomas of children: review of a 15‐year experience. Int J Radiat Oncol Biol Phys 28: 381–386. [DOI] [PubMed] [Google Scholar]

[b128] 128. Rubinstein L. (1972) Tumors of the central nervous system. Atlas of tumor pathology, 2nd series. Fascicle 6, Armed Forces Institute of Pathology: Washington DC . [Google Scholar]

[b129] 129. Rublo MP, Correa KM, Ramesn V., MacCollin MM, Jacooy LB, von Deimling A., Gusella JF, Louis DN (1994) Analysis of tne neurofibromatosis 2 gene in uuman ependymomas and astrocytomas. Cancer Res 54; 45–47. [PubMed] [Google Scholar]

[b130] 130. Rubio MP, von Deimling A., Yande DW, Wiestler OD, Gusella JF, Louis DN (1993) Accumuiation of wild‐tyce p53 protein in human astrocytomas. Career Res 53: 3465–3467. [PubMed] [Google Scholar]

[b131] 131. Sainati L., Montaldi A., Puttl MC, Giangaspera F., Rigebello L., Steila M., Zanesco L., Basso G. (1992) Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas Cancer Genet Cytogenet 59: 213–216. [DOI] [PubMed] [Google Scholar]

[b132] 132. Salazar OM, Rubin P., Bassano D., Marcia VA (1975) Improved survival of patients with intracranial epencymomas by irradiation: dose selection and field extension. Cancer 35: 1563–1573. [DOI] [PubMed] [Google Scholar]

[b133] 133. Salgalier M., Agius L., Yates A., Pearl D., Roberts W., Stephens R. (1990) Application of automated image anal ysis to demonstrate the correlation between, ras p21 expression and severity of gliomas. Biochem Biophysic Res Com 169:482–491. [DOI] [PubMed] [Google Scholar]

[b134] 134. Salgalier M., Pearl D., Stephens R. (1991) In situ hybridization with single‐stranded RNA probes to demonstrate infrequently elevated gli mRNA and no increased ras mRNA levels in meningiomas and astrocytomas Cancer Letters 57: 243–253. [DOI] [PubMed] [Google Scholar]

[b135] 135. Samuels V., Barrett JM, Bockman S., Pantazis CG, Allen MB, Jr. (1989) Immonocytochemical study of transforming growth factor expression, in benign and malignant gliomas. Am J Pathol 134: 894–902. [PMC free article] [PubMed] [Google Scholar]

[b136] 136. Sato T., Shimoda A., Takahashi T., Kurokawa H., Arco M., Goto S., Takamura H. (1984) Congenital anaplastic ependymoma: a case report of famlliai giloma. Childs Brain 11: 342–348. [DOI] [PubMed] [Google Scholar]

[b137] 137. Savard ML, Gilchrist DM (1989) Eoendymomas in two sisters and a maternal male cousin with mosaicism with monosomy 22 in tumour. Pediatr Neuroscr 15: 80–84. [DOI] [PubMed] [Google Scholar]

[b138] 138. Sawyer JR, Sammartino G., Husain M., Boop FA, Chadduck WM (1994) Chromosome aberrations in four ependymomas. Cancer Genet Cytogenet 74: 132–138. [DOI] [PubMed] [Google Scholar]

[b139] 139. Saxena A., Clark WC, Robertson JT, Ikejiri B., Oldfield EH, Ali IU (1992) Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 52: 6716–6721. [PubMed] [Google Scholar]

[b140] 140. Scheurlen WG, Senf L. (1995) Analysis of the GAP‐related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors. Int J Cancer 64: 234–238. [DOI] [PubMed] [Google Scholar]

[b141] 141. Schiffer D., Chio A., Cravioto H., Giordana MT, Migheli A., Soffietti R., Vigliani MC (1991) Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery 29: 206–210. [PubMed] [Google Scholar]

[b142] 142. Schiffer D., Chio A., Giordana MT, Migheli A., Palma L., Pollo B., Soffietti R., Tribolo A. (1991) Histologic prognostic factors in ependymoma. Childs Nerv Syst 7: 177–182. [DOI] [PubMed] [Google Scholar]

[b143] 143. Schroder R., Ploner C., Ernestus RI (1993) The growth potential of ependymomas with varying grades of malignancy measured by the Ki‐67 labelling index and mitotic index. Neurosurg Rev 16: 145–150. [DOI] [PubMed] [Google Scholar]

[b144] 144. Seeger RC, Brodeur GM, Sather H., Dalton A., Siegel SE, Wong KY, Hammond D. (1985) Association of multiple copies of the N‐myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111–1116. [DOI] [PubMed] [Google Scholar]

[b145] 145. Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD (1987) Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13: 1457–1462. [DOI] [PubMed] [Google Scholar]

[b146] 146. Shuman RM, Alvord EC, Jr. , Leech RW (1975) The biology of childhood ependymomas. Arch Neurol 32: 731–739. [DOI] [PubMed] [Google Scholar]

[b147] 147. Sieb JP, Pulst SM, Buch A. (1992) Familial CNS tumors. J Neurol 239: 343–344. [DOI] [PubMed] [Google Scholar]

[b148] 148. Silber JR, Mueller BA, Ewers TG, Berger MS (1993) Comparison of 06‐methylguanine‐DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53: 3416–3420. [PubMed] [Google Scholar]

[b149] 149. Slave I., MacCollin MM, Dunn M., Jones S., Sutton L., Gusella JF, Biegel JA (1995) Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64: 243–247. [DOI] [PubMed] [Google Scholar]

[b150] 150. Steck PA, Ligon AH, Cheong P., Yung WK, Pershouse MA (1995) Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromes Cancer 12: 255–261. [DOI] [PubMed] [Google Scholar]

[b151] 151. Steinbok P., Hentschel S., Cochrane DD, Kestle JR (1996) Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg 84: 726–732. [DOI] [PubMed] [Google Scholar]

[b152] 152. Stratton MR, Darling J., Lantos PL, Cooper CS, Reeves BR (1989) Cytogenetic abnormalities in human ependymomas. Int J Cancer 44: 579–581. [DOI] [PubMed] [Google Scholar]

[b153] 153. Sutton LN, Goldwein J., Perilongo G., Lang B., Schut L., Rorke L., Packer R. (1990) Prognostic factors in childhood ependymomas. Pediatr Neurosurg 16: 57–65. [DOI] [PubMed] [Google Scholar]

[b154] 154. Thapar K., Fukuyama K., Rutka J. (1995) Neurogenetics and the molecular biology of human brain tumors. In: Brain Tumors, Kaye A., Laws E. Jr. (eds.), pp. 69–97, Churchill Livingstone: New York , NY . [Google Scholar]

[b155] 155. Thiel G., Marczinek K., Neumann R., Witkowski R., Marchuk DA, Nurnberg P. (1995) Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours. Anticancer Res 15: 2495–2499. [PubMed] [Google Scholar]

[b156] 156. Tominaga T., Kayama T., Kumabe T., Sonoda Y., Yoshimoto T. (1995) Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis. Acta Neurochir 135: 163–170. [DOI] [PubMed] [Google Scholar]

[b157] 157. Torp SH, Helseth E., Ryan L., Stolan S., Dalen A., Unsgaard G. (1991) Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res 11: 2095–2098. [PubMed] [Google Scholar]

[b158] 158. Trent J., Meltzer P., Rosenblum M., Harsh G., Kinzler K., Mashal R., Feinberg A., Vogelstein B. (1986) Evidence for rearrangement, amplification, and expression of c‐myc in a human glioblastoma. Proc Natl Acad Sci USA 83: 470–473. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b159] 159. Ueki K., Rubio MP, Ramesh V., Correa KM, Rutter JL, von Deimling A., Buckler AJ, Gusella JF, Louis DN (1994) MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3: 1841–1845. [DOI] [PubMed] [Google Scholar]

[b160] 160. Undjian S., Marinov M. (1990) Intracranial ependymomas in children. Childs Nerv Syst 6: 131–134. [DOI] [PubMed] [Google Scholar]

[b161] 161. Vagner‐Capodano AM, Gentet JC, Gambarelli D., Pellissier JF, Gouzien M., Lena G., Genitori L., Choux M., Raybaud C. (1992) Cytogenetic studies in 45 pediatric brain tumors. Pediatr Hematol Oncol 9: 223–235. [DOI] [PubMed] [Google Scholar]

[b162] 162. Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M. (1992) Intracranial ependymoma: long‐term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 23: 313–319. [DOI] [PubMed] [Google Scholar]

[b163] 163. von Schoultz E., Bixo M., Backstrom T., Silfvenius H., Wilking N., Henriksson R. (1990) Sex steroids in human brain tumors and breast cancer. Cancer 65: 949–952. [DOI] [PubMed] [Google Scholar]

[b164] 164. Vonhaken MS White EC, Daneshvarshyesther L., Sih S., Choi E., Kalra R., Cogen PH (1996) Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic ependymomas. Genes Chromes Cancer 17: 37–44. [DOI] [PubMed] [Google Scholar]

[b165] 165. Waha A., Baumann A., Wolf HK, Fimmers R., Neumann J., Kindermann D., Astrahantseff K., Blumcke I., Vondeimling A., Schlegel U. (1996) Lack of prognostic relevance of alterations in the epidermal growth factor receptor transforming growth factor‐alpha pathway in human astrocytic gliomas. J Neurosurg 85: 634–641. [DOI] [PubMed] [Google Scholar]

[b166] 166. Wasson JC, Saylors RLd, Zeltzer P., Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM (1990) Oncogene amplification in pediatric brain tumors, Cancer Res 50: 2987–2990. [PubMed] [Google Scholar]

[b167] 167. Weitman SD, Frazier KM, Kamen BA (1994) The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncol 21: 107–112. [DOI] [PubMed] [Google Scholar]

[b168] 168. Weremowicz S., Kupsky WJ, Morton CC, Fletcher JA (1992) Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytognet 61: 193–196. [DOI] [PubMed] [Google Scholar]

[b169] 169. Wernicke C., Thiel G., Lozanova T., Vogel S., Kintzel D., Janisch W., Lehmann K., Witkowski R. (1995) Involvement of chromosome 22 in ependymomas. Cancer Genet Cytognet 79: 173–176. [DOI] [PubMed] [Google Scholar]

[b170] 170. West C. (1985) Ependymomas: factors in clinical and diagnostic staging. Cancer 56: 1812–1816. [DOI] [PubMed] [Google Scholar]

[b171] 171. Westermark B., Nister M. (1995) Molecular genetics of human glioma. Curr Op Oncol 7: 220–225. [DOI] [PubMed] [Google Scholar]

[b172] 172. Wold WS, Mackey JK, Brackmann KH, Takemori N., Rigden P., Green M. (1978) Analysis of human tumors and human malignant cell lines for BK virus‐specific DNA sequences. Proc Natl Acad Sci USA 75: 454–458. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b173] 173. Wong AJ, Signer SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899–6903. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b174] 174. Wu JK, Chikaraishi DM (1990) Differential expression, of mos oncogene in primary human astrocytomas and astrocytoma cell lines. Cancer Res 50: 3032–3035. [PubMed] [Google Scholar]

[b175] 175. Wullich B., Muller HW, Fischer U., Zang KD, Meese E. (1993) Amplified met gene linked to double minutes in human glioblastoma. Eur J Cancer 29A: 1991–1995. [DOI] [PubMed] [Google Scholar]

[b176] 176. Wullich B., Sattler HP, Fischer U., Meese E. (1994) Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14: 577–579. [PubMed] [Google Scholar]

[b177] 177. Zagzag D., Miller DC, Sato Y., Rifkin DB, Burster, DE (1990) Immunohistochemical localization of basic flbroblast growth factor in astrocytomas. Cancer Res 50: 7393–7398. [PubMed] [Google Scholar]

PERMALINK

The Molecular Biology of Ependymomas

Ronald L Hamilton, M.D.

Ian F Pollack, M.D.

Abstract

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

The Molecular Biology of Ependymomas

Ronald L Hamilton, M.D.

Ian F Pollack, M.D.

Abstract

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases